Affiliation:
1. State Institution “City Disinfection Station”
2. State Institution “Research Institute of Preventive Medicine of Tajikistan”; State Educational Institution “Institute of Postgraduate Education in Healthcare of the Republic of Tajikistan”
Abstract
Aim. To evaluate the shifts in demographic, clinical, and epidemiological characteristics of patients with multidrugresistant tuberculosis (MDR TB) amidst the COVID-19 pandemic.Materials and Methods. A cross-sectional study was conducted on patients with MDR TB registered in Dushanbe, before (2017-2019) and during the COVID-19 pandemic (2020-2021).Results. The average age of patients prior to the COVID-19 pandemic was 36.5±16.9 years (1.7-79.4), whereas during the COVID-19 period, it was 34.4±17 years (2.9-80.2). The pandemic era witnessed a statistically significant rise in the proportion of workers among MDR TB patients compared to the unemployed (OR = 1.4; 95% CI 1.02-1.91; p = 0.05). Furthermore, an increase was observed in the proportion of patients with lung destruction in both newly diagnosed (OR 3.4; 95% CI 1.99–5.87; p<0.001) and previously treated patients (OR 4.2; 95% CI 1.38–12.99; p =0.002). There was also an increase in extrapulmonary tuberculosis registration (OR=1.7; 95% CI 1.34-2.22; p<0.001), indicating an unfavorable epidemiological situation in terms of MDR-TB. However, there were no statistically significant changes in the registration of concomitant diseases.Conclusion. We recommend the improvement of TB infection prevention and control measures at all levels, as well as the enhancement of early detection of TB and MDR TB patients by primary health care workers.
Reference14 articles.
1. Vasileva I.A. Epidemicheskaya situatsiya po tuberkulezu v gody pandemii COVID-19 – 2020-2021 gg. [Epidemic situation for tuberculosis in the years of the COVID-19 pandemic - 2020-2021.]. Tuberkulez i bolezni legkikh - Tuberculosis and lung diseases, 2022, No. 100 (3), pp. 6-12.
2. Makhmudova P.U. Effektivnost lecheniya bolnykh s lekarstvenno ustoychivymi formami tuberkulyoza lyogkikh v Respublike Tadzhikistan [Effectiveness of Treatment of Patients with DrugResistant Forms of Pulmonary Tuberculosis in the Republic of Tajikistan]. Vestnik Avitsenny - Avicenna Bulletin, 2018, Vol. 20, No. 2-3, pp. 235–239.
3. Ministerstvo zdravookhraneniya i sotsialnoy zashchity naseleniya Respubliki Tadzhikistan. Zdorove naseleniya i deyatelnost uchrezhdeniy zdravookhraneniya v Respublike Tadzhikistan [Ministry of Health and Social Protection of the Republic of Tajikistan. Population Health and Activities of Health Care Institutions in the Republic of Tajikistan]. Dushanbe, 2015-2020.
4. Natsionalnaya programma zashchity naseleniya ot tuberkulyoza v Respublike Tadzhikistan na 20212025 gody ot 27 fevralya 2021 goda, №49 [National program to protect the population from tuberculosis in the Republic of Tajikistan for 2021-2025, February 27, 2021, №49.].
5. Available at: http://www.adlia.tj/show_doc.fwx?Rgn=138961